Just reported
From Zimmer Biomet's results release of 4 novembre 2026; its quarterly report has since been filed.
Actual
2,06B USD
+3,1% y/y
-5,2% q/q
Guided
—
No guide given
Actual
1,00 USD
-14% y/y
-2,9% q/q
Guided
—
No guide given
Actual
307,6M USD
-12% y/y
-5,7% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Le quote di ricavo sono stime per six months ended June 30, 2026, non cifre tratte da un documento depositato.
Knee replacement implants
Artificial parts that replace all or part of a damaged knee, including components used in later repair or replacement procedures.
Hip replacement systems
Artificial parts that replace the ball and socket of the hip; some are fixed with bone cement and others are designed to attach directly to bone.
Sports medicine, extremities and trauma devices
Devices used to repair soft-tissue injuries, stabilize broken bones, and treat conditions in the foot, ankle, shoulder, elbow and wrist.
ROSA Robot
A surgical robot that helps surgeons position implants during certain knee, hip and shoulder procedures.
ZBEdge
A group of robotic and digital technologies that gathers information before, during and after surgery to help inform patient care.
Bone cement
Cement and related mixing and delivery products used to attach some orthopedic implants to bone.
Zimmer Biomet makes artificial knees and hips, as well as devices used to repair injuries to bones, joints, and surrounding soft tissue. Surgeons use its ROSA robot to help position implants during some operations. Hospitals and surgery centers buy products directly or through distributors and dealers; many products are kept on consignment for use when a procedure is scheduled.
Costruito dai documenti depositati da Zimmer Biomet Holdings, Inc. presso la Securities and Exchange Commission (SEC), l’autorità di vigilanza statunitense. Le cifre sono quelle dichiarate, con lo storico per azione ricalcolato sulla base azionaria di oggi. Questo descrive un’azienda: non è consulenza finanziaria né una raccomandazione di acquisto o vendita.
104,61 USD-2,7%chiusura 12 nov
Dati fino al 30 settembre 2026, dal 10-Q depositato il 4 novembre 2026
Zimmer Biomet sells knee and hip replacement implants and other devices for bone and joint surgery to hospitals, surgery centers, and surgeons.
The themes Zimmer Biomet is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Grade B
La fascia sotto il prezzo mostra il voto in ogni data, calcolato solo sui documenti già pubblici in quel momento.
Mostra 2 trimestri su 41 dello storico dei voti di Zimmer Biomet Holdings, Inc.. Gli altri 39 risalgono fino a novembre 2016.